Zhejiang Hisun Pharmaceutical Co Ltd (600267) — Financial Flexibility Index
Zhejiang Hisun Pharmaceutical Co Ltd (600267) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥541.12 Million (operating CF CN¥438.43 Million minus capex CN¥102.69 Million) represents 0% of total liabilities (CN¥6.56 Billion). Also explore 600267 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Zhejiang Hisun Pharmaceutical Co Ltd Financial Flexibility Index (1999–2025)
Historical Financial Flexibility Index trend for Zhejiang Hisun Pharmaceutical Co Ltd across 27 annual periods. Check Zhejiang Hisun Pharmaceutical Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Zhejiang Hisun Pharmaceutical Co Ltd (1999–2025)
Year-by-year free cash flow to debt coverage for Zhejiang Hisun Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Zhejiang Hisun Pharmaceutical Co Ltd market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | CN¥2.41 Billion | CN¥2.03 Billion | CN¥6.20 Billion | ▲ +22.0% |
| 2024 | 0.32x | CN¥2.35 Billion | CN¥2.11 Billion | CN¥7.39 Billion | ▲ +67.8% |
| 2023 | 0.19x | CN¥1.76 Billion | CN¥1.52 Billion | CN¥9.26 Billion | ▼ -23.7% |
| 2022 | 0.25x | CN¥2.60 Billion | CN¥2.07 Billion | CN¥10.45 Billion | ▲ +26.7% |
| 2021 | 0.20x | CN¥2.36 Billion | CN¥1.74 Billion | CN¥12.03 Billion | ▲ +8.3% |
| 2020 | 0.18x | CN¥2.28 Billion | CN¥1.59 Billion | CN¥12.60 Billion | ▲ +40.6% |
| 2019 | 0.13x | CN¥1.77 Billion | CN¥698.39 Million | CN¥13.78 Billion | ▼ -38.8% |
| 2018 | 0.21x | CN¥3.05 Billion | CN¥1.45 Billion | CN¥14.48 Billion | ▲ +7.2% |
| 2017 | 0.20x | CN¥2.70 Billion | CN¥1.24 Billion | CN¥13.76 Billion | ▼ -1.8% |
| 2016 | 0.20x | CN¥2.54 Billion | CN¥775.90 Million | CN¥12.72 Billion | ▼ -17.4% |
| 2015 | 0.24x | CN¥2.66 Billion | CN¥736.17 Million | CN¥11.01 Billion | ▼ -19.9% |
| 2014 | 0.30x | CN¥2.73 Billion | CN¥571.04 Million | CN¥9.03 Billion | ▼ -8.6% |
| 2013 | 0.33x | CN¥2.65 Billion | CN¥527.25 Million | CN¥8.01 Billion | ▼ -11.6% |
| 2012 | 0.37x | CN¥2.01 Billion | CN¥375.75 Million | CN¥5.37 Billion | ▼ -25.3% |
| 2011 | 0.50x | CN¥1.82 Billion | CN¥525.31 Million | CN¥3.64 Billion | ▲ +19.3% |
| 2010 | 0.42x | CN¥1.33 Billion | CN¥509.18 Million | CN¥3.18 Billion | ▼ -13.0% |
| 2009 | 0.48x | CN¥1.33 Billion | CN¥472.85 Million | CN¥2.77 Billion | ▲ +42.6% |
| 2008 | 0.34x | CN¥869.53 Million | CN¥221.28 Million | CN¥2.57 Billion | ▼ -27.6% |
| 2007 | 0.47x | CN¥751.07 Million | CN¥437.72 Million | CN¥1.61 Billion | ▲ +70.0% |
| 2006 | 0.27x | CN¥423.70 Million | CN¥108.03 Million | CN¥1.54 Billion | ▼ -1.0% |
| 2005 | 0.28x | CN¥382.28 Million | CN¥113.53 Million | CN¥1.38 Billion | ▼ -56.6% |
| 2004 | 0.64x | CN¥625.46 Million | CN¥312.93 Million | CN¥977.76 Million | ▲ +2.8% |
| 2003 | 0.62x | CN¥542.35 Million | CN¥288.45 Million | CN¥871.96 Million | ▲ +28.2% |
| 2002 | 0.49x | CN¥364.20 Million | CN¥120.82 Million | CN¥750.69 Million | ▼ -25.3% |
| 2001 | 0.65x | CN¥334.46 Million | CN¥69.14 Million | CN¥514.75 Million | ▲ +12.9% |
| 2000 | 0.58x | CN¥258.46 Million | CN¥55.70 Million | CN¥449.01 Million | ▲ +60.0% |
| 1999 | 0.36x | CN¥151.88 Million | CN¥32.64 Million | CN¥422.24 Million | — |